To our knowledge, this is the first study to demonstrate the potential harmful effects of ATB exposure in Chinese ES‐SCLC patients receiving anti‐PD1/PD‐L1‐based immunotherapy. The gene discussed is CD274; the disease is small cell lung carcinoma.